Opaleye Management Inc. Fortress Biotech, Inc. Transaction History

Opaleye Management Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.65 $366,800 - $851,500	-1,310,000 Reduced 39.58%	2,000,000 $580,000
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.82 $619,164 - $1.04 Million	-1,263,600 Reduced 27.63%	3,310,000 $1.82 Million
Q1 2023 May 12, 2023	BUY	$0.65 - $1.1 $1.64 Million - $2.78 Million	2,523,600 Added 123.1%	4,573,600 $3.75 Million
Q4 2022 Feb 10, 2023	SELL	$0.48 - $13.5 $455,520 - $12.8 Million	-949,000 Reduced 31.64%	2,050,000 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $196,062 - $5.46 Million	-248,180 Reduced 7.64%	2,999,000 $2.58 Million
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $402,256 - $754,230	-502,820 Reduced 13.41%	3,247,180 $2.73 Million
Q3 2021 Nov 16, 2021	SELL	$2.82 - $3.7 $352,500 - $462,500	-125,000 Reduced 3.23%	3,750,000 $12.1 Million
Q1 2021 May 18, 2021	SELL	$3.16 - $4.89 $39,500 - $61,124	-12,500 Reduced 0.32%	3,875,000 $13.7 Million
Q4 2020 Feb 12, 2021	BUY	$2.2 - $4.45 $126,500 - $255,875	57,500 Added 1.5%	3,887,500 $12.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.83 - $3.16 $7.01 Million - $12.1 Million	3,830,000 New	3,830,000 $10.3 Million
Q2 2018 Aug 14, 2018	SELL	$2.92 - $5.1 $919,800 - $1.61 Million	-315,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$3.42 - $5.35 $1.08 Million - $1.69 Million	315,000 New	315,000 $1.43 Million

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.